Do BBH and FBT hold the same stocks?

By their latest filings, 41% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, BBH or FBT?

BBH has 64% of its weight in S&P 500 names and FBT has 25%, so FBT differs more from the index.

Which is cheaper, BBH or FBT?

BBH charges 0.35% a year and FBT charges 0.55%, so BBH is cheaper. Fees come from each fund's prospectus.

Data as of Nov 4, 2026.

Thematic ETFs

BBH vs FBT: Holdings Overlap & Returns

Share on X Download as PDF

Over the year to Nov 4, 2026, BBH returned +47.2% to FBT's +47.0%; 41% of their weight is in the same names.

askIQ about this page

askIQ about BBH and FBT

Net assets on Nov 3, 2026: $525m for VanEck Biotech ETF and $3.1bn for First Trust NYSE Arca Biotechnology Index Fund.

BBH on its own →FBT on its own →

At a glance

64.4%

BBH in the S&P 500

24.8%

FBT in the S&P 500

+47.2%

BBH total return, 1 year

+47.0%

FBT total return, 1 year

BBH · 1 year to Nov 4, 2026 36% of its weight is outside the S&P 500

64% of BBH's weight is in S&P 500 companies and 36% is outside the index. Holdings as of Nov 2, 2026.

FBT · 1 year to Nov 4, 2026 75% of its weight is outside the S&P 500

25% of FBT's weight is in S&P 500 companies and 75% is outside the index. Holdings as of Nov 3, 2026.

Pair scorecard

BBH costs 0.20 points a year less; their one-year returns differ by 0.2 points; FBT is 5.9 times larger.

BBH vs FBT: Holdings Overlap & Returns
Measure	BBH	FBT
Return
Measure	BBH	FBT
Total return, 1 year	+47.2%	+47.0%
Benchmark
Measure	BBH	FBT
What it tracks	Biotech	Biotech
Cost and size
Measure	BBH	FBT
Expense ratio	0.35%	0.55%
Net assets, as of Nov 3, 2026	$525m	$3.1bn
Holdings
Measure	BBH	FBT
Holdings in common	41%

Method

Risk and return

Dec 30, 2011 to Oct 30, 2026 · 774 weekly returns

BBH FBT

Return

Total return edge FBT +644.8% +771.8%

Annualized edge FBT (slight) +14.4% +15.7%

Price return edge FBT +608.2% +752.9%

Risk

Volatility edge BBH (slight) 22.2% 23.5%

Max drawdown edge Tie −37.7% −38.2%

Risk-adjusted

Sharpe edge FBT (slight) 0.64 0.66

Sortino edge FBT (slight) 0.96 1.00

Calmar edge FBT (slight) 0.38 0.41

Reading

From Dec 2011 to Oct 2026, FBT returned more: +771.8% to +644.8%. BBH swung slightly less: 22.2% to 23.5%. BBH and FBT fell about the same at their worst: −37.7% and −38.2%.

Full scorecard

9 measures, with how each is measured Open ↓

Risk and return: BBH vs FBT: Holdings Overlap & Returns
Measure	BBH	FBT	Edge	How it is measured
Return
Total return	+644.8%	+771.8%	FBT	Price change plus distributions, reinvested.
Annualized	+14.4%	+15.7%	FBT (slight)	Total return as a yearly rate.
Price return	+608.2%	+752.9%	FBT	Price change alone, distributions left out.
Risk
Volatility	22.2%	23.5%	BBH (slight)	Spread of weekly returns, annualized. Lower is steadier.
Downside deviation	14.9%	15.5%	BBH (slight)	Like volatility, counting only weeks below the Treasury bill rate.
Max drawdown	−37.7%	−38.2%	Tie	Deepest fall from a high to the low after it.
Risk-adjusted
Sharpe	0.64	0.66	FBT (slight)	Return above Treasury bills per unit of volatility.
Sortino	0.96	1.00	FBT (slight)	Return above Treasury bills per unit of downside deviation.
Calmar	0.38	0.41	FBT (slight)	Annualized return divided by the max drawdown.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 774 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

41%

By the books each fund has filed, BBH and FBT hold 41% of their money in the same securities at the same weight. Holdings dated Nov 3, 2026.

50%

0 half 100%

half

41% in common

Positions both hold · largest shared weight first BBH FBT

Regeneron Pharmaceuticals Inc 7.99% 4.18%

Amgen Inc 16.53% 3.57%

Gilead Sciences Inc 14.17% 3.56%

Argenx Se 4.13% 3.51%

Vertex Pharmaceuticals Inc 7.98% 3.34%

Natera Inc 4.44% 3.11%

Biogen Inc 2.88% 3.54%

Illumina Inc 3.37% 2.75%

Beone Medicines Ltd 2.56% 3.21%

United Therapeutics Corp 2.38% 3.51%

Incyte Corp 2.07% 3.35%

Alnylam Pharmaceuticals Inc 1.68% 2.21%

Only in one fund ↓

Only in BBH

Moderna Inc 6.88%

Iqvia Holdings Inc 4.18%

Revolution Medicines Inc 3.82%

Guardant Health Inc 2.83%

Insmed Inc 1.85%

Charles River Laboratories Internationa 1.71%

Icon Plc 1.43%

Qiagen Nv 1.02%

Only in FBT

Genmab A/S (ADR) 4.81%

Exelixis, Inc. 3.88%

Halozyme Therapeutics, Inc. 3.74%

Alkermes Plc 3.61%

Veracyte, Inc. 3.57%

TG Therapeutics, Inc. 3.52%

ADMA Biologics, Inc. 3.44%

NeoGenomics, Inc. 3.30%

Check overlap with more funds →

Window by window

Window by window: BBH vs FBT: Holdings Overlap & Returns
	Total return
Window	BBH	FBT
3 months	+24.3%	+12.2%
6 months	+38.3%	+30.5%
1 year	+47.2%	+47.0%
3 years	+75.4%	+100.5%
Since launchNot the same days: BBH Dec 2011 · FBT Jun 2006	+680.5%	+1,349.5%

Open this comparison in the app →

Side by side

BBH VanEck Biotech ETF · Holds 25 stocks in biotech, 64% of its weight in S&P 500 companies FBT First Trust NYSE Arca Biotechnology Index Fund · Holds 30 stocks in biotech, 25% of its weight in S&P 500 companies

Issuer VanEck First Trust

Theme Biotech Biotech

In the S&P 500 64.4% 24.8%

Active share vs the S&P 500 99.0% 99.1%

In the Nasdaq-100 49.1% 16.9%

Holdings 25 30

Top ten, share of the fund 73.5% 38.2%

Expense ratio 0.35% 0.55%

Fee for the differing part 0.35% 0.55%

Total return, 1 year +47.2% +47.0%

vs its benchmark not measured not measured

Below its high 0.0% −0.3%

Net assets, as of Nov 3, 2026 $525m $3.1bn

As of Nov 4, 2026. Source: ETFIQ.

41% of the two portfolios are the same securities at the same weight.

Client brief:

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

About each fund

BBH

By weight, 64% of BBH's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 74% of the fund across 25 positions, as published by its issuer for Nov 3, 2026. Over the year to Nov 4, 2026 the fund returned +47.2% with distributions reinvested.

FBT

By weight, 25% of FBT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 38% of the fund across 30 positions, as published by its issuer for Nov 3, 2026. Over the year to Nov 4, 2026 the fund returned +47.0% with distributions reinvested.

Questions people ask

Do BBH and FBT hold the same stocks?: By their latest filings, 41% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, BBH or FBT?: BBH has 64% of its weight in S&P 500 names and FBT has 25%, so FBT differs more from the index.
Which is cheaper, BBH or FBT?: BBH charges 0.35% a year and FBT charges 0.55%, so BBH is cheaper. Fees come from each fund's prospectus.

Other comparisons

BBH vs BBP BBH vs XBI BBH vs IBB BBH vs PBPH FBT vs IBB FBT vs PBE FBT vs PBPH FBT vs IBBQ

Where to next

All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →BBH on its own →FBT on its own →BBH dividend history →BBH holdings →FBT dividend history →FBT holdings →Method →Standards and sources →

Sources and dates

BBH filings on SEC EDGAR ↗

BBH prospectus with the expense ratio (SEC) ↗

VanEck website ↗

FBT filings on SEC EDGAR ↗

FBT prospectus with the expense ratio (SEC) ↗

First Trust page for FBT ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, BBH against FBT, data as of Nov 4, 2026. https://etfiq.com/compare/themes/bbh-vs-fbt

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.